Yes, as of 28 November, the IND submission was going to be submitted in (mid) December with the expectation that the company would hear back from the FDA sometime in February and the ADPKD trial would commence sometime in March or April.
Having already given that guidance, PYC may not announce the submission but I would expect that we will be informed next month if and when FDA clearance has been achieved.
PYC Price at posting:
$1.20 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)